Cel Sci (CVM) Invested Capital (2010 - 2026)
Cel Sci (CVM) posted Invested Capital of $6.8 million for Q1 2026, down 7.62% sequentially from $7.4 million in Q4 2025, and down 23.82% YoY from $9.0 million in Q1 2025.
Cel Sci (CVM) Invested Capital (2010 - 2026) Analysis & Trends
Cel Sci has reported Invested Capital for 16 years, with the latest figure at $6.8 million in Q1 2026.
- Quarterly Invested Capital fell 23.82% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.7 million (down 20.99% YoY) and the FY2025 annual result came in at $8.0 million, down 20.0% from the prior year.
- Invested Capital eased to $6.8 million in Q1 2026 per CVM's latest filing, from $7.4 million in the prior quarter.
- Over five years, Invested Capital peaked at $13.3 million in Q3 2022 and troughed at $6.8 million in Q1 2026.
- A 5-year average of $9.7 million and a median of $9.7 million in 2024 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2022 and 2026: Invested Capital decreased 1.48% in 2022, then decreased 23.82% in 2026.
- Over 5 years, Invested Capital stood at $13.3 million in 2022, then slipped by 15.08% to $11.3 million in 2023, then decreased by 16.02% to $9.5 million in 2024, then dropped by 21.86% to $7.4 million in 2025, then retreated by 7.62% to $6.8 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $6.8 million, $7.4 million, and $8.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - | 6.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.85 Mn |
| Dec 31, 2025 | 7.41 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 8.48 Mn |
| Mar 31, 2025 | 8.99 Mn |
| Dec 31, 2024 | 9.49 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 10.43 Mn |
| Mar 31, 2024 | 10.88 Mn |
| Dec 31, 2023 | 11.30 Mn |
| Sep 30, 2023 | 11.70 Mn |
| Sep 30, 2022 | 13.30 Mn |
| Sep 30, 2021 | 13.50 Mn |
| Jun 30, 2021 | 14.10 Mn |
| Mar 31, 2021 | 12.10 Mn |
| Dec 31, 2020 | 12.50 Mn |
| Sep 30, 2020 | 12.70 Mn |
| Jun 30, 2020 | 12.90 Mn |
| Mar 31, 2020 | 13.10 Mn |
| Dec 31, 2019 | 13.28 Mn |